Cornerstone Wealth Management LLC Acquires New Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cornerstone Wealth Management LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 5,776 shares of the exchange traded fund’s stock, valued at approximately $520,000.

Several other large investors have also recently bought and sold shares of XBI. Hartline Investment Corp raised its stake in shares of SPDR S&P Biotech ETF by 2.0% during the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after acquiring an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after purchasing an additional 125 shares during the period. Denver Wealth Management Inc. raised its position in SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 127 shares during the last quarter. Trust Co. of Vermont lifted its holdings in SPDR S&P Biotech ETF by 4.7% during the 3rd quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after buying an additional 138 shares during the period. Finally, Graypoint LLC grew its position in shares of SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after buying an additional 146 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $92.46 on Friday. The business has a 50-day moving average of $93.34 and a 200-day moving average of $96.89. The company has a market capitalization of $7.05 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.